EUVIMEDEUVIMED entdecken
Crossref

Dihydroartemisinin Alleviates Chronic Allograft Rejection by Inhibiting Tfh and B Cells While Promoting Treg Cells in Murine Cardiac Transplantation

Xiaoyi Shi, Zhe Yang, Wenli Zeng, Chenfang Luo, Jinru Zhang, Changqing Qu, Jianning Wang iD, Qipeng Sun, Tao Liao iD

Immunology · 2025

DOI: 10.1111/imm.70093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Xiaoyi Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Artemisinins, Heart Transplantation, T-Lymphocytes, Regulatory, Graft Rejection. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Joint Innovation Team for Clinical & Basic Research, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicular helper T (Tfh), B and regulatory T (Treg) cells are involved in the pathogenesis of chronic rejection (CR) after transplantation. Dihydroartemisinin (DHA) is an antimalarial drug with anti‐inflammatory activity; however, the effects and mechanisms of DHA on Tfh, B and Treg cells have not been comprehensively elucidated. The aim of this study was to investigate the effect of DHA on Tfh, B and Treg cells and its preventive effect on CR. In vitro assays demonstrated that DHA not only blocks the induction of Tfh cells and alleviates their supportive effect on B cell differentiation but also directly suppresses B cell activation, differentiation and antibody production. Additionally, DHA promotes the induction of Treg cells and enhances their stability in an inflammatory environment. In vivo studies showed that DHA effectively alleviated CR by suppressing neointimal hyperplasia, myocardial injury and interstitial fibrosis and reducing inflammatory cell infiltration and C4d deposition in allografts. Moreover, DHA decreased the levels of Tfh, germinal centre Tfh, B, germinal centre B, IgG‐producing and plasma cells in recipients but increased Treg cell levels in recipients and allografts. Mechanistically, we confirmed that DHA inhibits Tfh cells by blocking IL‐2‐inducible T cell kinase signalling, suppresses B cells by blocking Bruton's tyrosine kinase signalling, and enhances Treg cells by blocking mTOR signalling while promoting STAT5 signalling. In conclusion, our results verified that DHA inhibits Tfh and B cells and enhances Treg cells to attenuate CR in mice, highlighting its potential applicability in the development of robust treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsHeart TransplantationT-Lymphocytes, RegulatoryGraft RejectionB-LymphocytesT Follicular Helper CellsT-Lymphocytes, Helper-InducerAnimalsMiceLymphocyte ActivationMice, Inbred C57BLCell DifferentiationMice, Inbred BALB CMaleDisease Models, AnimalSignal Transduction

Stichwörter der Autor:innen

B cellschronic rejectiondihydroartemisininfollicular helper T cellsregulatory T cells

Substanzen

artenimolArtemisinins

Autor:innen und Institutionen

  • Department of Organ Transplantation, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China.
  • Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Jianning Wang, Tao Liao

Förderung

  • National Natural Science Foundation of China
  • Joint Innovation Team for Clinical & Basic Research
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Shi, X., Yang, Z., Zeng, W., Luo, C., Zhang, J., Qu, C., Wang, J., Sun, Q., & Liao, T. (2025). Dihydroartemisinin Alleviates Chronic Allograft Rejection by Inhibiting Tfh and B Cells While Promoting Treg Cells in Murine Cardiac Transplantation. Immunology. https://doi.org/10.1111/imm.70093

Vancouver

Shi X, Yang Z, Zeng W, Luo C, Zhang J, Qu C, et al. Dihydroartemisinin Alleviates Chronic Allograft Rejection by Inhibiting Tfh and B Cells While Promoting Treg Cells in Murine Cardiac Transplantation. Immunology. 2025. doi:10.1111/imm.70093

BibTeX
@article{Shi2025,
  author = {Shi, Xiaoyi and Yang, Zhe and Zeng, Wenli and Luo, Chenfang and Zhang, Jinru and Qu, Changqing and Wang, Jianning and Sun, Qipeng and Liao, Tao},
  title = {Dihydroartemisinin Alleviates Chronic Allograft Rejection by Inhibiting Tfh and B Cells While Promoting Treg Cells in Murine Cardiac Transplantation},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.70093}
}
Kostenlos starten →